UMIN-ICDS History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000062879
Receipt number	R000071992
Scientific Title	Translational Research of the FIRST-RCC Study: A Multicenter Retrospective Study on the Efficacy and Safety of First-Line Treatment with Nivolumab plus Cabozantinib or Pembrolizumab plus Lenvatinib for Advanced or Metastatic Renal Cell Carcinoma
Date of disclosure of the study information	2026/09/10
Last modified on	2026/09/10 22:31:22

---